<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Regulatory actions</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Regulatory actions for April 17, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adimab, Aicuris, Bavarian Nordic, Cumberland, Fertilai, Grifols, Mabwell, Medera, Royal Philips, Savara, Surgentec, Waiv.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730415</guid>
      <pubDate>Fri, 17 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730415-regulatory-actions-for-april-17-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 16, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Airs, Aligos, AOP, Arbutus, ARS, Cala, C-mo, Dogwood, Immutep, Leadiant, Leo, Northstar, Opna, Partner, Reach Surgical, Waters, Xspray.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730401</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730401-regulatory-actions-for-april-16-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 15, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Grace, Holling, Ligand, Nxera, Praxis, Protaryx, Radical Catheter, Renaissance, Toby, Travere.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730320</guid>
      <pubDate>Wed, 15 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730320-regulatory-actions-for-april-15-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 14, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Beckman Coulter Diagnostics, Daiichi, Kymera, Merck, Prosomnus, Regeneron, Replimune, Roche, Sanofi.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730305</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730305-regulatory-actions-for-april-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 14, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Duality, GSK, Lynk, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730368</guid>
      <pubDate>Tue, 14 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730368-regulatory-actions-for-april-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 13, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Boxspine, Difgen, Duality Biologics, GSK, Lynk, Medcad, Sibel, Sobi, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730291</guid>
      <pubDate>Mon, 13 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730291-regulatory-actions-for-april-13-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 10, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Duality, Glenmark, Macrogenics, Modular Medical, Novo Nordisk.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730233</guid>
      <pubDate>Fri, 10 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730233-regulatory-actions-for-april-10-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 9, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Anumana, Bausch + Lomb, Becton Dickinson, Cortec, Endospan, Etiometry, GSK, Plus, United, Waters.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730219</guid>
      <pubDate>Thu, 09 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730219-regulatory-actions-for-april-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 8, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Artivion, Ascendis, Baylis, Climb Bio, Invera, Neuropacs, Nextcure, Nuvalent, NX Development, Organogenesis, Outlook, Royal Biologics, Savara.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730159</guid>
      <pubDate>Wed, 08 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730159-regulatory-actions-for-april-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Allevion, Regeneron, Stereotaxis.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730145</guid>
      <pubDate>Tue, 07 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730145-regulatory-actions-for-april-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 7, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Abbisko, Eisai, GSK, Merck, SS Innovations.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730114</guid>
      <pubDate>Tue, 07 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730114-regulatory-actions-for-april-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 6, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cocrystal, Context, Fore, Eli Lilly, Merck, Ultragenyx, Zeto.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730131</guid>
      <pubDate>Mon, 06 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730131-regulatory-actions-for-april-6-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 2, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: A2 Biotherapeutics, Abbisko, Baebies, Bioxcel, Chiesi, Cogent, Orca, Ray, Restore Robotics, Serenity, Vertex.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730085</guid>
      <pubDate>Thu, 02 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730085-regulatory-actions-for-april-2-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 1, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Ascendis, Elevar, Haemonetics, Medibeacon, Oculis, Polypid, Praxis, Sanofi, Scholar Rock.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729988</guid>
      <pubDate>Wed, 01 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729988-regulatory-actions-for-april-1-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 31, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Anumana, Biogen, Boston Scientific, Bridgebio, Butterfly, Chiesi, Egetis, Eisai,Elevar, GSK, Merck, Nanoscope, Roche, Savara, SS Innovations, Sobi, Teva, Zymeworks.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729974</guid>
      <pubDate>Tue, 31 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729974-regulatory-actions-for-march-31-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 31, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Deciphera, Eisai, GC, GSK, Immunitybio, Mars Bioimaging, Nuvation, Ono, OS Therapies, Pharming, Regeneron, Sanofi, Tarsus, Viatris.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729994</guid>
      <pubDate>Tue, 31 Mar 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729994-regulatory-actions-for-march-31-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 30, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: ARS, Bavarian Nordic, Crinetics, Eisai, GSK, Johnson & Johnson, Medtronic, Novo Nordisk, Nuvation Bio, OS Therapies, Pharming, Rocket, Sanofi, Siga.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729960</guid>
      <pubDate>Mon, 30 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729960-regulatory-actions-for-march-30-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 27, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 3D Systems, Agilent, Corcept, Deciphera, Deepecho, Denali, Fennec, GC Biopharma, Invivoscribe, Ono, Rhythm, Royal Philips, Soligenix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729925</guid>
      <pubDate>Fri, 27 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729925-regulatory-actions-for-march-27-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 26, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Anavex, Apotex, Ferring, Kallisio, OS Therapies, Pixee, Quoin, Triana.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729911</guid>
      <pubDate>Thu, 26 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729911-regulatory-actions-for-march-26-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 25, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cephx, GE, Liviwell, Mars, Pharming, QT Imaging, Regeneron, Sanofi.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729849</guid>
      <pubDate>Wed, 25 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729849-regulatory-actions-for-march-25-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 24, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: BMS, GSK, Immunitybio, Ionis, Tarsus, Viatris.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729835</guid>
      <pubDate>Tue, 24 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729835-regulatory-actions-for-march-24-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 24, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Argo, Belief, Fujirebio, Gyre, H.U. Groupe, Peijia Medical, Sun, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729741</guid>
      <pubDate>Tue, 24 Mar 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729741-regulatory-actions-for-march-24-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 23, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Eledon, Intrabio, Novo Nordisk, Rhythm, Siemens.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729821</guid>
      <pubDate>Mon, 23 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729821-regulatory-actions-for-march-23-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 20, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Belief Biomed, Fluoguide, GSK, Livanova, Nia, Remix, Sarepta.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729768</guid>
      <pubDate>Fri, 20 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729768-regulatory-actions-for-march-20-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 19, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: J&J, Jenavalve, Mammotmoe, Myriad, Peijia, Roche, Sanofi, Spinal Elements.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729754</guid>
      <pubDate>Thu, 19 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729754-regulatory-actions-for-march-19-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 18, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aldeyra, Biocardia, Fujirebio, Gyre, H.U. Group, Humacyte, Oxos, Perfuze, Polaryx, Polypid.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729570</guid>
      <pubDate>Wed, 18 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729570-regulatory-actions-for-march-18-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 17, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Argo, Astrazeneca, Cogent, Glafabra, Koru Medical, Novartis, Roche, Sun, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729556</guid>
      <pubDate>Tue, 17 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729556-regulatory-actions-for-march-17-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 17, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Daiichi Sankyo, Junshi, Nanosonics, Ultragreen.ai.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729576</guid>
      <pubDate>Tue, 17 Mar 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729576-regulatory-actions-for-march-17-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 16, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aminex, GSK, Mineralys.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729542</guid>
      <pubDate>Mon, 16 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729542-regulatory-actions-for-march-16-2026</link>
    </item>
    <item>
      <title>Regulatory actions for March 13, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atara, Johnson & Johnson, Pierre, Toro, Ultragreen, Xspray.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729504</guid>
      <pubDate>Fri, 13 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729504-regulatory-actions-for-march-13-2026</link>
    </item>
  </channel>
</rss>
